Does chemotherapy have a role in the management of craniopharyngioma?

Journal of Pediatric Endocrinology and Metabolism

Volumn 19, Issue SUPPL. 1, 2006, Pages 407-412

  Hargrave, Darren R ^a  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

Bleomycin; Chemotherapy; Craniopharyngioma; Intra cavitary; Local; Systemic

Indexed keywords

ALPHA INTERFERON; BLEOMYCIN; CARMUSTINE; CISPLATIN; DOXORUBICIN; LACTATE DEHYDROGENASE; LOMUSTINE; MIDAZOLAM; PARACETAMOL; PHOSPHORUS 32; PROCARBAZINE; VINCRISTINE;

ALOPECIA; BLEEDING; BLOOD TOXICITY; BONE MARROW DEPRESSION; CANCER COMBINATION CHEMOTHERAPY; CANCER RELAPSE; CHEMOTHERAPY INDUCED EMESIS; CHILDHOOD CANCER; CORRELATION ANALYSIS; CRANIOPHARYNGIOMA; DOSE RESPONSE; DRUG DOSE REDUCTION; DRUG FATALITY; DRUG FEVER; DRUG INDUCED HEADACHE; DRUG MEGADOSE; ENDOCRINE DISEASE; FLU LIKE SYNDROME; HEARING IMPAIRMENT; HUMAN; INFARCTION; LIBRARY; LIVER TOXICITY; MALIGNANT NEOPLASTIC DISEASE; MEDLINE; NAUSEA; NEUROTOXICITY; PERSONALITY DISORDER; REVIEW; SEIZURE; SKIN TOXICITY; SOMNOLENCE; STEREOTAXIC SURGERY; SURGICAL APPROACH; SYSTEMATIC REVIEW; TREATMENT OUTCOME; TREATMENT WITHDRAWAL; VISUAL IMPAIRMENT;

ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; BLEOMYCIN; CHILD; CRANIOPHARYNGIOMA; DRUG DELIVERY SYSTEMS; HUMANS; INJECTIONS; PITUITARY NEOPLASMS;

EID: 33646197309     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (29)

1. Hayward R. The present and future management of childhood craniopharyngioma. Childs Nerv Syst 1999; 15: 764-769.
2. Hoffman HJ. Surgical management of craniopharyngioma. Pediatr Neurosurg 1994; 21 (Suppl 1): 44-49.
3. Carpentieri SC, Waber DP, Pomeroy SL, Scott RM, Goumnerova LC, Kieran MW, Billett AL, Tarbell NJ. Neuropsychological functioning after surgery in children treated for brain tumor. Neurosurgery 2003; 52: 1348-1356.
4. Cavazzuti V, Fischer EG, Welch K, Belli JA, Winston KR. Neurological and psychophysiological sequelae following different treatments of craniopharyngioma in children. J Neurosurg 1983; 59: 409-417.
5. Alen JF, Boto GR, Lagares A, de la Lama A, Gomez PA, Lobato RD. Intratumoural bleomycin as a treatment for recurrent cystic craniopharyngioma. Case report and review of the literature. Neurocirugia (Astur) 2002; 13: 479-485.
6. Park DH, Park JY, Kim JH, Chung YG, Lee HK, Lee KC, Suh JK. Outcome of postoperative intratumoral bleomycin injection for cystic craniopharyngioma. J Korean Med Sci 2002; 17: 254-259.
7. Jiang R, Liu Z, Zhu C. Preliminary exploration of the clinical effect of bleomycin on craniopharyngiomas Stereotact Funct Neurosurg 2002; 78: 84-94.
8. Mottolese C, Stan H, Hermier M, Berlier P, Convert J, Frappaz D, Lapras C. Intracystic chemotherapy with bleomycin in the treatment of craniopharyngiomas, Childs Nerv Syst 2001; 17: 724-730.
9. Hader WJ, Steinbok P, Hukin J, Fryer C. Intratumoral therapy with bleomycin for cystic craniopharyngiomas in children. Pediatr Neurosurg 2000; 33: 211-218.
10. Savas A, Erdem A, Tun K, Kanpolat Y. Fatal toxic effect of bleomycin on brain tissue after intracystic chemotherapy for a craniopharyngioma case report. Neurosurgery 2000; 46: 213-216.
11. Savas A, Arasil E, Batay F, Selcuki M, Kanpolat Y. Intracavitary chemotherapy of polycystic craniopharyngioma with bleomycin. Acta Neurochir (Wien) 1999; 141: 547-548.
12. Sagoh M, Murakami H, Hirose Y, Mayanagi K. Occlusive cerebrovasculopathy after internal radiation and bleomycin therapy for craniopharyngioma-case report. Neurol Med Chir (Tokyo) 1997; 37: 920-923.
13. Cavalheiro S, Sparapani FV, Franco JO, da Silva MC, Braga FM. Use of bleomycin in intratumoral chemotherapy for cystic craniopharyngioma. Case report. J Neurosurg 1996; 84: 124-126.
14. Haisa T, Ueki K, Yoshida S. Toxic effects of bleomycin on the hypothalamus following its administration into a cystic craniopharyngioma. Br J Neurosurg 1994; 8: 747-750.
15. Takahashi H, Nakazawa S, Shimura T. Evaluation of postoperative intratumoral injection of bleomycin for craniopharyngioma in children. J Neurosurg 1985; 62: 120-127.
16. Laws ER Jr, Morris AM, Maartens N. Gliadel for pituitary adenomas and craniopharyngiomas. Neurosurgery 2003; 53: 255-269.
17. Plowman PN, Besser GM, Shipley J, Summersgill B, Geddes J, Afshar F. Dramatic response of malignant craniopharyngioma to cis-platin-based chemotherapy. Should craniopharyngioma be considered as a suprasellar 'germ cell' tumour? Br J Neurosurg 2004; 18: 500-505.
18. Lippens RJ, Rotteveel JJ, Otten BJ, Merx H. Chemotherapy with adriamycin (doxorubicin) and CCNU (lomustine) in four children with recurrent craniopharyngioma. Eur J Paediatr Neurol 1998; 2: 263-268.
19. Bremer AM, Nguyen TQ, Balsys R. Therapeutic benefits of combination chemotherapy with vincristine, BCNU, and procarbazine on recurrent cystic craniopharyngioma. A case report. J Neurooncol 1984; 2: 47-51.
20. Jakacki RI, Cohen BH, Jamison C, Mathews VP, Arenson E, Longee DC, Hilden J, Cornelius A, Needle M, Heilman D, Boaz JC, Luerssen TG. Phase II evaluation of interferon-alpha-2a for progressive or recurrent craniopharyngiomas. J Neurosurg 2000; 92: 255-260.
21. De Vile CJ, Grant DB, Hayward RD, Kendall BE, Neville BG, Stanhope R. Obesity in childhood craniopharyngioma: relation to post-operative hypothalamic damage shown by magnetic resonance imaging. J Clin Endocrinol Metab 1996; 81: 2734-2737.
22. De Vile CJ, Grant DB, Kendall BE, Neville BG, Stanhope R, Watkins KE, Hayward RD. Management of childhood craniopharyngioma: Can the morbidity of radical surgery be predicted? J Neurosurg 1996; 85: 73-81.
23. Bin-Abbas B, Mawlawi H, Sakati N, Khafaja Y, Chaudhary MA, Al Ashwal A. Endocrine sequelae of childhood craniopharyngioma. J Pediatr Endocrinol Metab 2001; 14: 869-874.
24. Brada M, Thomas DG. Craniopharyngioma revisited. Int J Radiat Oncol Biol Phys 1993; 27: 471-475.
25. Wisoff JH. Surgical management of recurrent craniopharyngiomas. Pediatr Neurosurg 1994; 21 (Suppl 1): 108-113.
26. Broggi G, Franzini A, Cajola L, Pluchino F. Cell kinetic investigations in craniopharyngioma: preliminary results and considerations. Pediatr Neurosurg 1994; 21 (Suppl 1): 21-23.
27. Broggi G, Franzini A. Bleomycin for cystic craniopharyngioma. J Neurosurg 1996; 84: 1080-1081.
28. Nishida K, Honda H, Ueki K. [Studies on craniopharyngioma in tissue culture - author's transl]. Neurol Med Chir (Tokyo) 1980; 20: 247-255.
29. Kubo O, Takakura K, Miki Y, Okino T, Kitamura K. [Intracystic therapy of bleomycin for craniopharyngioma - effect of bleomycin for cultured craniopharyngioma cells and intracystic concentration of bleomycin - author's transl]. No Shinkei Geka 1974; 2: 683-688.